Exploring how older adults perceived the impact of infectious diseases and vaccines on ageing: a cross-sectional study in France
Abstract
This cross-sectional study examined perceptions of health and ageing, and their influence on vaccine acceptance among individuals aged 65 and older living at home in the Auvergne-Rhône-Alpes region of France. Anonymous online questionnaires were distributed to users of CARSAT Rhône-Alpes (N1 = 50,000) and Auvergne (N2 = 9,597). The 62-question survey covered vaccination perceptions, the impact of the Covid-19 pandemic, health concerns, preventive measures, health information sources, and vaccination history. Vaccine hesitancy was assessed using the 5 C model, categorizing respondents into the group ‘Opposed’, ‘Hesitant’, and ‘Very Favourable’ to vaccination based on vaccination history and reasons for non-vaccination. Out of 3,331 respondents, 2,416 questionnaires were analysable. Most participants identified stroke (43.4%), cancer (20.4%), and dementia (18%) as primary health concerns. Infectious diseases ranked lowest, with pneumonia (1.24%), Covid-19 (0.89%), influenza (0.43%), and shingles (0.11%) infrequently cited. The Hesitant group more frequently questioned vaccination recommendations (82%) compared to the Very Favourable group (74%). Opposed participants significantly doubted vaccine efficacy and its role in healthy aging, differing from Hesitant and Very Favourable participants (p < 0.001). Perceptions of vulnerability to infection and beliefs about the seriousness of vaccine-preventable diseases significantly differed among groups (p < 0.001), with higher…
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.